Integrating Drug-Related Problems Identification and INA-CBGs Cost Gap Analysis in Hemorrhagic Stroke Patients with Hypertension: A PCNE-Based Systematic Review
DOI:
https://doi.org/10.37287/ijghr.v7i6.151Keywords:
DRP, hemorrhagic stroke, hypertension, INA-CBGs, PCNE, pharmacoeconomicsAbstract
Hemorrhagic stroke with comorbid hypertension is a complex clinical condition with a high economic burden. In the National Health Insurance (JKN) financing system, INA-CBG package rates often do not reflect the actual costs incurred by hospitals. One potential factor contributing to this cost gap is Drug-Related Problems (DRPs), which include incorrect dosing, drug interactions, and inappropriate therapy.Objective to assess the impact of DRPs on the cost gap between INA-CBG tariffs and actual costs of hemorrhagic stroke care with hypertension, as well as to evaluate the effectiveness of the PCNE method in identifying DRPs. Following PRISMA guidelines, a literature search was conducted on PubMed, ScienceDirect, ProQuest, and Google Scholar (2020–2025) using keywords related to hemorrhagic stroke, hypertension, cost-effectiveness, INA-CBGs, and PCNE. Primary studies analyzing DRPs and/or comparing actual costs with INA-CBGs tariffs in hemorrhagic stroke patients were included. The data were synthesized narratively, focusing on types of DRPs, application of PCNE, and cost gaps. Of 195 articles, 11 were included in the synthesis, with 3 highly relevant. DRPs (eg, inappropriate drug selection) were detected in over 60% of cases using PCNE, leading to increased costs. The gap between actual costs and INA-CBGs tariffs reached up to IDR 8 million. DRPs are significant determinants of cost inefficiency in the care of hemorrhagic stroke patients with hypertension. Systematic implementation of the PCNE method integrated with pharmacoeconomic evaluation is recommended to support the sustainability of JKN. This study suggests tariff adjustments for INA-CBGs and an expanded role for pharmacists.
References
Abdul-Ghaffar, F., Redzuan, A.M., Makmor-Bakry, M., & Nor, M.A.M. (2022). Drug-related problems in pulmonary hypertension with valvular heart disease. Therapeutics and Clinical Risk Management , 18, 1069–1079. https://doi.org/10.2147/TCRM.S374291
Abushanab, D., Atchan, M., Elajez, R., Elshafei, M., Abdelbari, A., Al Hail, M., ... & Al-Badriyeh, D. (2023). Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar . PLOS ONE, 18(6), e0286419. https://doi.org/10.1371/journal.pone.0286419
Amorim, FJR de, Valença-Feitosa, F., Rios, MC, Souza, CAS, Barros, IM da C., Oliveira Filho, AD de, & Lyra Júnior, DP de. (2021). Pharmacoeconomic impact of hospital clinical pharmacy services: Protocol for an overview of systematic reviews . JMIR Preprints. https://doi.org/10.2196/preprints.35865
Bhusal, T., Bista, D., & Shrestha, R. K. (2025). Study on risk factors and associated drug related problems in patients with stroke. BMC Neurology, 25(1). https://doi.org/10.1186/s12883-025-04130-7
Pharmaciae Indonesia, A. (2024). Evaluation of drug use in stroke patients at the inpatient unit of Brebes Hospital, Central Java. 12(1), 11944. https://doi.org/10.20884/1.api.2024.12.01.11944
Chen, Q., Jin, Z., Zhang, P., Sun, S., Li, L., & Liao, Y. (2020). Characteristics of drug-related problems among hospitalized ischemic stroke patients in China. International Journal of Clinical Pharmacy, 42(4), 1237–1241. https://doi.org/10.1007/s11096-020-01081-6
Girotra, T., Lekoubou, A., Bishu, K.G., & Ovbiagele, B. (2020). A contemporary and comprehensive analysis of the costs of stroke in the United States. Journal of the Neurological Sciences, 410. https://doi.org/10.1016/j.jns.2019.116643
Kaban, PLRA, Ginting, CN, & Nasution, SW (2023). Analysis of Stroke Patient Care Costs at Royal Prima Hospital in 2020. Silampari Nursing Journal, 6(2), 1644–1654. https://doi.org/10.31539/jks.v6i2.5324
Ministry of Health of the Republic of Indonesia. (2023). Regulation of the Minister of Health of the Republic of Indonesia Number 3 of 2023 concerning Standard Tariffs for Health Services in the Implementation of the Health Insurance Program . Jakarta: Ministry of Health of the Republic of Indonesia
Kusumawardani LA, Andrajati R, Nusaibah A. Drug-related problems in hypertensive patients: A cross-sectional study from Indonesia. J Res Pharm Pract 2020;9:140-5.
Mahardika, IGAPD, Nita, Y., & Priyandani, Y. (2024). A comparative study of real hospital costs and INA-CBG rates for stroke in Indonesia. Pharmacy Education, 24(3), 166–172. https://doi.org/10.46542/pe.2024.243.166172
Murgiati, SR, & Alim, MDM (2024). Profile of antihypertensive use in stroke patients at Samarinda Medika Citra Hospital. Farmamedika Journal, 9 (2), 195–202.
Pharmaceutical Care Network Europe (PCNE). (2020). PCNE Classification for Drug-Related Problems V9.1 . Retrieved from https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf
Priya, K., Sreshta, M., & Philip, S. (2021). Cost-saving medication therapy management for outpatients. Perspectives in Clinical Research, 12(1), 14–20. https://doi.org/10.4103/picr.PICR_164_18
Radne Rimba, I., Dwinta, E., & Undergraduate Pharmacy Studies, P. (nd). PHARMACEUTICAL JOURNAL OF INDONESIA Comparative Analysis and Cost of Illness of Ischemic Stroke with Hemorrhagic Stroke in Inpatients at Panembahan Senopati Regional Hospital. In PHARMACEUTICAL JOURNAL OF INDONESIA 2021 (Vol. 7, Issue 1). http://.pji.ub.ac.id
Saldanha V, Randall Martins R, Lima SIVC, et al. Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort. BMJ Open 2020;10:e035848. doi:10.1136/ bmjopen-2019-035848
Simonetti, L., Lefrant, J., Cireașă, B., et al. (2024). Pharmacoeconomic and clinical impact of pharmaceutical services in the intensive care unit: a systematic review . European Journal of Hospital Pharmacy. Advance online publication. https://doi.org/10.1136/ejhpharm-2024-004208
Siskou, O.; Galanis, P.; Konstantakopoulou, O.; Stafylas, P.; Karagkouni, I.; Tsampalas, E.; Garefou, D.; Alexopoulou, H.; Gamvroula, A.; Lypiridou, M.; et al. The Cost and Value of Stroke Care in Greece: Results from the SUN4P Study. Healthcare 2023, 11, 2545. https://doi.org/10.3390/ healthcare11182545
Susanti, R., Umillia Purwanti, N., Hadari Nawawi, J., & Barat, K. (2025). Identification of Drug Related Problems (DRPs) in the Treatment of Stroke Patients with a History of Hypertension at Tanjungpura University Hospital, Pontianak. Journal of Pharmaceutical Sciences , 6 (1).
Wenny, R., Susanti, R., & Purwantia, NU (2025). Identification of Drug-Related Problems (DRPs) in the Treatment of Stroke Patients with a History of Hypertension at Tanjungpura University Hospital, Pontianak. Lumbung Farmasi: Journal of Pharmaceutical Sciences, 6(1), 86–92.
World Stroke Organization. (2025). Global stroke fact sheet 2025 . Retrieved from https://www.world-stroke.org
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
